Open AccessCurcumin in chronic lymphocytic leukemia – A review
Author(s) -
Vagish Kumar L Shanbhag
Publication year - 2017
Publication title -
asian pacific journal of tropical biomedicine/asian pacific journal of tropical biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 61
eISSN - 2588-9222
pISSN - 2221-1691
DOI - 10.1016/j.apjtb.2017.05.003
Subject(s) - chronic lymphocytic leukemia , curcumin , medicine , leukemia , cancer , toxicity , oncology , cancer research , pharmacology
Curcumin is a widely researched natural product and is known to possess anti-carcinogenic properties. Chronic lymphocytic leukemia is a type of leukemia that principally affects patients with age higher than 60 years. Since the toxicity of conventional drugs exceeds the benefits of treating this leukemia type, patients are treated only in the advanced symptomatic stages. The current article reviews curcumin, its general actions and targets in cancer, and specifically that of it in chronic lymphocytic leukemia